Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL471776 | 0.92 | FAAH (0.59) | NAAAFAAHRAD52NPSR1 | |
| SCHEMBL14195455 | 0.80 | NAAA (0.47) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL6759011 | 0.80 | NAAA (0.62) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL10712018 | 0.80 | NAAA (0.49) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL11184931 | 0.80 | NAAA (0.67) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL5067226 | 0.80 | NAAA (0.67) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL5497221 | 0.80 | NAAA (0.67) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL11676519 | 0.79 | NAAA (0.60) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL11676939 | 0.79 | NAAA (0.60) | NAAAFAAHRAD52NPSR1EPHX1 | |
| SCHEMBL11676081 | 0.79 | NAAA (0.60) | NAAAFAAHRAD52NPSR1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 867 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240011976-A1 | ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE | BECKMAN COULTER, INC. | 2024-01-11 | — | — | US | claimed |
| CN-116997797-A | Additives for reducing non-specific interactions between fluorescent polymer conjugates and cells in biological samples | 贝克曼库尔特有限公司 | 2023-11-03 | — | — | CN | claimed |
| EP-4244625-A1 | ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE | Beckman Coulter, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| WO-2022104147-A1 | ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE | BECKMAN COULTER, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| US-20080124292-A1 | for coating the eyelashes; at least one C16-C30 fatty acid and at least one basic amino acid,at least one glutamic acid compound and/or one of its salts, at least one sarcosine compound | L'OREAL (FR) | 2008-05-29 | — | — | US | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| EP-4263777-B1 | BIODEGRADABLE POLYMERS | BASF SE (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4728032-A1 | STABILIZED CLEANING COMPOSITIONS COMPRISING EDDS AND ENZYMES AND THEIR USE | BASF SE (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4186969-B1 | SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION | HENKEL AG & CO KGAA (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-20260070696-A1 | LIQUID CONTAINER AND CAP | PROCTER & GAMBLE (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4705374-A1 | BIODEGRADABLE POLYOL PROPOXYLATES, THEIR PREPARATION, USES, AND COMPOSITIONS COMPRISING THEM | BASF SE (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4547341-B1 | REDUCED PALM KERNEL RELIANT WASH COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-03-04 | — | — | EP | disclosed |
| EP-4695321-A1 | VINYL ACETATE HAVING LOW DEUTERIUM CONTENT | BASF SE (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-1133545-A1 | ALL PURPOSE CLEANER WITH DIQUATERNARY POLYSILOXANE | Goldschmidt AG (DE) | 2001-09-19 | — | — | EP | disclosed |
| WO-2001030958-A1 | AQUEOUS MULTIPLE PHASE DETERGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-05-03 | — | — | WO | disclosed |
| WO-2001029172-A1 | DISHWASHER DETERGENT PORTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2000065020-A1 | HAND DISH WASHING DETERGENT WITH MICROCAPSULES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-11-02 | — | — | WO | disclosed |
| WO-2000031224-A1 | ALL PURPOSE CLEANER WITH DIQUATERNARY POLYSILOXANE | GOLDSCHMIDT AG (DE) | 2000-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070696-A1 | LIQUID CONTAINER AND CAP | CAPRIN1, CAPG, CAPZA2 | NAAA 4043/4885FAAH 1906/4885RAD52 2497/4885 |
| US-20080124292-A1 | for coating the eyelashes; at least one C16-C30 fatty acid and at least one basic amino acid,at least one glutamic acid compound and/or one of its salts, at least one sarcosine compound | S100A10, SGMS1, ACBD3 | NAAA 914/4885FAAH 314/4885RAD52 3507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.